Skip to main navigation Skip to search Skip to main content

Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin in patients with chronic hepatitis C virus genotype 1 infection receiving opioid substitution therapy: A post hoc analysis of 12 clinical trials

  • Jason Grebely
  • , Massimo Puoti
  • , Heiner Wedemeyer
  • , Curtis Cooper
  • , Mark S. Sulkowski
  • , Graham R. Foster
  • , Thomas Berg
  • , Erica Villa
  • , Federico Rodriguez-Perez
  • , David L. Wyles
  • , Gretja Schnell
  • , Negar N. Alami
  • , Zhenzhen Zhang
  • , Emily Dumas
  • , Gregory J. Dore

Research output: Contribution to journal › Article › peer-review

4   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin in patients with chronic hepatitis C virus genotype 1 infection receiving opioid substitution therapy: A post hoc analysis of 12 clinical trials'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases

Immunology and Microbiology